Patent: Virucidal compounds and use thereof
Virucidal compounds and use thereof
cris.legacyId | 310996 | |
cris.virtual.author-scopus | 6603088116 | |
cris.virtual.author-scopus | 10244557300 | |
cris.virtual.department | SUNMIL | |
cris.virtual.department | LPDI | |
cris.virtual.orcid | 0000-0003-4635-6080 | |
cris.virtual.orcid | 0000-0002-7377-8636 | |
cris.virtual.parent-organization | AVP-R | |
cris.virtual.parent-organization | VPA-AVP-R | |
cris.virtual.parent-organization | VPA | |
cris.virtual.parent-organization | EPFL | |
cris.virtual.rid | B-1990-2008 | |
cris.virtual.sciperId | 196998 | |
cris.virtual.sciperId | 294375 | |
cris.virtual.sciperId | 253103 | |
cris.virtual.sciperId | 291907 | |
cris.virtual.sciperId | 265333 | |
cris.virtual.unitId | 10021 | |
cris.virtual.unitManager | Correia, Bruno | |
cris.virtual.unitManager | Crottini, Andrea | |
cris.virtual.unitManager | Stellacci, Francesco | |
cris.virtualsource.author-scopus | 0ac6c172-cd12-412c-b61a-ce02c7433a9b | |
cris.virtualsource.author-scopus | f3ea3811-a735-443c-b623-49fbcb6ed5a4 | |
cris.virtualsource.author-scopus | c66834f7-742c-487f-a22d-84537a01c555 | |
cris.virtualsource.author-scopus | 45e89a74-dd61-4144-8749-10e2b5f7cb15 | |
cris.virtualsource.author-scopus | 3d60dff5-f474-4f55-b576-43b764f91a0a | |
cris.virtualsource.department | 0ac6c172-cd12-412c-b61a-ce02c7433a9b | |
cris.virtualsource.department | f3ea3811-a735-443c-b623-49fbcb6ed5a4 | |
cris.virtualsource.department | c66834f7-742c-487f-a22d-84537a01c555 | |
cris.virtualsource.department | 45e89a74-dd61-4144-8749-10e2b5f7cb15 | |
cris.virtualsource.department | 3d60dff5-f474-4f55-b576-43b764f91a0a | |
cris.virtualsource.orcid | 0ac6c172-cd12-412c-b61a-ce02c7433a9b | |
cris.virtualsource.orcid | f3ea3811-a735-443c-b623-49fbcb6ed5a4 | |
cris.virtualsource.orcid | c66834f7-742c-487f-a22d-84537a01c555 | |
cris.virtualsource.orcid | 45e89a74-dd61-4144-8749-10e2b5f7cb15 | |
cris.virtualsource.orcid | 3d60dff5-f474-4f55-b576-43b764f91a0a | |
cris.virtualsource.parent-organization | 2e28ebfd-ace7-4495-9fba-1736cc3ad29a | |
cris.virtualsource.parent-organization | 2e28ebfd-ace7-4495-9fba-1736cc3ad29a | |
cris.virtualsource.parent-organization | 2e28ebfd-ace7-4495-9fba-1736cc3ad29a | |
cris.virtualsource.parent-organization | 2e28ebfd-ace7-4495-9fba-1736cc3ad29a | |
cris.virtualsource.parent-organization | 2e28ebfd-ace7-4495-9fba-1736cc3ad29a | |
cris.virtualsource.rid | 0ac6c172-cd12-412c-b61a-ce02c7433a9b | |
cris.virtualsource.rid | f3ea3811-a735-443c-b623-49fbcb6ed5a4 | |
cris.virtualsource.rid | c66834f7-742c-487f-a22d-84537a01c555 | |
cris.virtualsource.rid | 45e89a74-dd61-4144-8749-10e2b5f7cb15 | |
cris.virtualsource.rid | 3d60dff5-f474-4f55-b576-43b764f91a0a | |
cris.virtualsource.sciperId | 0ac6c172-cd12-412c-b61a-ce02c7433a9b | |
cris.virtualsource.sciperId | f3ea3811-a735-443c-b623-49fbcb6ed5a4 | |
cris.virtualsource.sciperId | c66834f7-742c-487f-a22d-84537a01c555 | |
cris.virtualsource.sciperId | 45e89a74-dd61-4144-8749-10e2b5f7cb15 | |
cris.virtualsource.sciperId | 3d60dff5-f474-4f55-b576-43b764f91a0a | |
cris.virtualsource.unitId | 2e28ebfd-ace7-4495-9fba-1736cc3ad29a | |
cris.virtualsource.unitManager | 7cea022a-8ecc-4480-bfcb-d49de28e2850 | |
cris.virtualsource.unitManager | 2e28ebfd-ace7-4495-9fba-1736cc3ad29a | |
cris.virtualsource.unitManager | 6c681c85-4ddf-4b6c-a557-b71e6bb58a8c | |
datacite.rights | metadata-only | |
dc.contributor.author | Tapparel Vu, Caroline | |
dc.contributor.author | Correia, Bruno | |
dc.contributor.author | Gainza Cirauqui, Pablo | |
dc.contributor.author | Stevens, Corey Alfred | |
dc.contributor.author | Stellacci, Francesco | |
dc.contributor.author | Richter, Lukasz | |
dc.contributor.author | Olgiati, Francesca | |
dc.contributor.author | Medaglia, Chiara | |
dc.date.accessioned | 2024-05-06T13:20:41 | |
dc.date.available | 2024-05-06T13:20:41 | |
dc.date.created | 2024-05-06 | |
dc.date.issued | 2024 | |
dc.date.modified | 2025-05-28T07:44:09.664957Z | |
dc.description.abstract | Disclosed herein are peptide-grafted compounds that irreversibly deactivate bacteriophages or influenza virus depending on the peptide and remain safe for bacteria and mammalian cells. The active compounds comprise a core (cyclodextrin or gold nanoparticle) coated with a hydrophobic chain terminated with a peptide selective for bacteriophages or for influenza. Further, said compounds can be used directly inside the environment of the bioreactor, but they are also a safe additive to stocks of antibiotics and expression inducers (such as isopropyl ß-D-1-thiogalactopyranoside, i.e., IPTG), that cannot be autoclaved and are a common source of phage infections. The anti-influenza compound may be used as a drug to be given in therapeutic or prophylactic mode to fight influenza infection. | |
dc.description.notes | Alternative title(s) : (fr) Composés virucides et leur utilisation | |
dc.description.sponsorship | AVP-R-TTO | |
dc.identifier.epo | 90738470 | |
dc.identifier.patentno | WO2024086510 | |
dc.identifier.uri | ||
dc.title | Virucidal compounds and use thereof | |
dc.type | patent | |
dspace.entity.type | Patent | |
dspace.legacy.oai-identifier | oai:infoscience.epfl.ch:310996 | |
epfl.curator.email | ||
epfl.lastmodified.email | ||
epfl.legacy.itemtype | Patents | |
epfl.legacy.submissionform | PATENT | |
epfl.oai.currentset | OpenAIREv4 | |
epfl.patent.date | 2024-04-25 | |
epfl.patent.kindcode | A1 | |
epfl.tto | TTO:6.1514 | |
epfl.writtenAt | EPFL | |
oairecerif.patent.country | WO |
Files
License bundle
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: